Whalesbook
Zydus Lifesciences Ltd. has signed an exclusive licensing and commercialization agreement with US-based RK Pharma Inc. for a novel sterile injectable oncology supportive care product for the United States market. RK Pharma will handle manufacturing and supply, while Zydus will manage the New Drug Application (NDA) submission and US commercialization, aiming for a 2026 filing. This partnership aims to improve patient care and access to affordable medicines.